Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression
2020 · New England Journal of Medicine · 523 citations
https://doi.org/10.1056/nejmoa1904398
A
Axel Baumgarten
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
153
Papers
3.0K
Citations
27
h-index
47
i10-index
Axel Baumgarten is an academic researcher from Diagnostic and Treatment Centre Berlin. The author has contributed to research in topics: Hepatitis C virus research & Liver Disease Diagnosis and Treatment & Hepatitis B Virus Studies. The author has an h-index of 27, co-authored 131 publications.
Papers by this author
worksLong-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials
2020 · JAIDS Journal of Acquired Immune Deficiency Syndromes · 137 citations
https://doi.org/10.1097/qai.0000000000002466
Low incidence of HIV infection and decreasing incidence of sexually transmitted infections among PrEP users in 2020 in Germany
2022 · Infection · 25 citations
https://doi.org/10.1007/s15010-022-01919-3
Is doxycycline post-exposure prophylaxis being utilised in Germany? Insights from an online survey among German men who have sex with men
2024 · Infection · 11 citations
https://doi.org/10.1007/s15010-024-02321-x
A seroprevalence study indicates a high proportion of clinically undiagnosed MPXV infections in men who have sex with men in Berlin, Germany
2024 · BMC Infectious Diseases · 10 citations
https://doi.org/10.1186/s12879-024-10066-z
Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) After A Viremic Event: A Pooled Analysis of Studies in People with HIV
2025 · Infectious Diseases and Therapy · 4 citations
https://doi.org/10.1007/s40121-025-01153-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat